Last updated on September 2018

Registrational Study With Omecamtiv Mecarbil/AMG 423 to Treat Chronic Heart Failure With Reduced Ejection Fraction


Contact Investigators or Research Sites near you

Start Over

Amgen Call Center

Research Site
Haskovo, Bulgaria
2.8miles
  Connect »